Deeg H J, Storb R, Thomas E D
Br J Haematol. 1984 Jun;57(2):185-208.
In one and one-half decades, marrow transplantation has become a life-saving procedure for an ever-increasing number of patients. With continued observation, however, it became apparent that marrow transplantation as used presently is associated with significant acute, delayed, and chronic toxicity. These complications may be related to chemo- or radiotherapy used in conditioning for transplantation, to immunosuppressive treatment given after transplantation and to the immunodeficiency associated with transplantation and the development of GVHD. Attempts need to be made to develop less toxic conditioning regimens. Most importantly, however, we need to learn more about mechanisms of graft-host interaction in order to eliminate the problem of GVHD and to accelerate the recovery of immunocompetence in allogeneic chimaeras.
在十五年的时间里,骨髓移植已成为越来越多患者的救命疗法。然而,随着持续观察,目前使用的骨髓移植显然与显著的急性、延迟性和慢性毒性相关。这些并发症可能与移植预处理中使用的化疗或放疗、移植后给予的免疫抑制治疗以及与移植相关的免疫缺陷和移植物抗宿主病(GVHD)的发生有关。需要努力开发毒性较小的预处理方案。然而,最重要的是,我们需要更多地了解移植物与宿主相互作用的机制,以消除GVHD问题,并加速异基因嵌合体免疫能力的恢复。